Phase 1 6 trials
Phase 1
NCT07382726 Jul 2026 → Dec 2027 expected non-small cell lung carcinoma M.D. Anderson Cancer Center
Not yet recruiting
No outcome recorded
Phase 1
NCT05983432 Aug 2023 → Dec 2026 expected cervical cancer , endometrial cancer , esophageal cancer , head and neck squamous cell carcinoma +6 SystImmune Inc.
Recruiting
No outcome recorded
Phase 1
NCT05470348 Aug 2022 → Dec 2026 expected breast cancer Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 1
NCT05393427 Feb 2022 → Dec 2025 overdue malignant urinary system neoplasm Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 1
NCT05262491 Feb 2022 → Dec 2026 expected digestive system neoplasm Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 1
NCT05194982 Nov 2021 → Dec 2026 expected —
Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 1/2 3 trials
Phase 1/2
NCT07307053 Jan 2026 → Jan 2029 expected high grade malignant neoplasm , metastatic neoplasm Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
No outcome recorded
Phase 1/2
NCT06618287 Feb 2025 → Feb 2031 expected breast cancer , lung cancer Bristol-Myers Squibb
Recruiting
No outcome recorded
Phase 1/2
NCT05803018 Jun 2023 → Dec 2026 expected female reproductive organ cancer Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2 22 trials
Phase 2
NCT07054567 Aug 2025 → May 2027 expected cervical cancer , endometrial cancer Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06962787 Jul 2025 → May 2027 expected kidney cancer Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06951464 Jun 2025 → May 2027 expected non-small cell lung carcinoma Sichuan University
Recruiting
No outcome recorded
Phase 2
NCT06986785 Jun 2025 → May 2027 expected hepatocellular carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06978114 Jun 2025 → May 2027 expected biliary tract cancer Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06787664 Jan 2025 → Jun 2027 expected chordoma Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 2
NCT06598787 Oct 2024 → Oct 2026 expected glioblastoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06471205 Aug 2024 → Jul 2026 overdue triple-negative breast carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06498986 Jul 2024 → Aug 2026 overdue non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06475300 Jun 2024 → Jul 2026 overdue nasopharyngeal carcinoma , non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06437509 Jun 2024 → Jun 2026 overdue small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06437522 Jun 2024 → Jun 2026 overdue head and neck squamous cell carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06405425 May 2024 → May 2026 overdue urothelial carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT05956587 Jan 2024 → Dec 2026 expected nasopharyngeal carcinoma , non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06042894 Dec 2023 → Dec 2026 expected breast cancer Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT05965856 Dec 2023 → Dec 2026 expected urothelial carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06008054 Nov 2023 → Dec 2026 expected colorectal cancer , esophageal cancer , gastric cancer Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT05924841 Nov 2023 → Dec 2026 expected small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT05990803 Nov 2023 → Dec 2026 expected cervical cancer Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT06006169 Oct 2023 → Dec 2026 expected head and neck squamous cell carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2
NCT05880706 Jul 2023 → Jul 2027 expected non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 2
NCT05785039 Apr 2023 → Dec 2026 expected urinary system neoplasm Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Show 12 more trials Phase 2/3 6 trials
Phase 2/3
NCT07554456 Jun 2026 → Dec 2028 expected esophageal squamous cell carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 2/3
NCT07642024 Jun 2026 → Dec 2032 expected non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 2/3
NCT07641855 Jun 2026 → Dec 2028 expected castration-resistant prostate carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 2/3
NCT07100080 Nov 2025 → Dec 2028 expected non-small cell lung carcinoma Bristol-Myers Squibb
Recruiting
No outcome recorded
Phase 2/3
NCT07106762 Sep 2025 → Jan 2029 expected urothelial carcinoma Bristol-Myers Squibb
Recruiting
No outcome recorded
Phase 2/3
NCT06926868 Sep 2025 → Mar 2028 expected breast neoplasm Bristol-Myers Squibb
Recruiting
No outcome recorded
Phase 3 15 trials
Phase 3
NCT07680790 Sep 2026 → Dec 2031 expected non-small cell lung carcinoma Bristol-Myers Squibb
Not yet recruiting
No outcome recorded
Phase 3
NCT07582315 Jul 2026 → Dec 2028 expected biliary tract cancer Sichuan Baili Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT07648914 Jun 2026 → Dec 2028 expected breast cancer Sichuan Baili Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT07640789 Jun 2026 → Dec 2030 expected non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT07502300 Apr 2026 → Dec 2029 expected small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Not yet recruiting
No outcome recorded
Phase 3
NCT06994195 Aug 2025 → Jun 2027 expected fallopian tube cancer , malignant epithelial tumor of ovary , primary peritoneal carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 3
NCT06857175 Mar 2025 → Jun 2027 expected urothelial carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 3
NCT06838273 Feb 2025 → Dec 2028 expected non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 3
NCT06500026 Aug 2024 → Dec 2026 expected small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 3
NCT06382142 Jun 2024 → Jun 2026 overdue triple-negative breast carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 3
NCT06382116 May 2024 → May 2026 overdue non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 3
NCT06382129 May 2024 → Dec 2026 expected non-small cell lung carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 3
NCT06343948 Apr 2024 → May 2026 overdue hormone receptor-positive breast cancer Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 3
NCT06304974 Mar 2024 → May 2026 overdue esophageal squamous cell carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Phase 3
NCT06118333 Dec 2023 → Nov 2026 expected nasopharyngeal carcinoma Sichuan Baili Pharmaceutical Co., Ltd.
Active not recruiting
No outcome recorded
Show 5 more trials